Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule

Author:
  • Ola Lindén
  • F Tennvall
  • Eva Cavallin-Ståhl
  • Lennart Darte
  • Tomas G Ohlsson
  • Cecilia Hindorf
  • Karin Wingårdh
  • Sven-Erik Strand
Publishing year: 2001
Language: English
Pages: 602-602
Publication/Series: Blood
Volume: 98
Issue: 11
Document type: Journal article
Publisher: American Society of Hematology

Keywords

  • Hematology

Other

Published
  • ISSN: 1528-0020
Sven-Erik Strand
E-mail: sven-erik [dot] strand [at] med [dot] lu [dot] se

Project manager

Systemic Radiation Therapy Group

32

Professor emeritus

Medical Radiation Physics, Lund

32